ArticleCureus2026
Effects of Platelet-Rich Plasma Injection in Knee Osteoarthritis Stages 1-4: A Retrospective Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aim Knee osteoarthritis (OA) is a common degenerative joint disorder and a major cause of pain and disability. Platelet-rich plasma (PRP) injections have evolved as an option for the management of knee OA. However, there is a need for studies across different populations and geographic regions. The aim of this study was to assess the outcomes of PRP injections in different stages of knee OA in the Arab population of Kuwait. Methods Data were collected retrospectively. Outcome measures were the Verbal Numerical Rating Scale (VNRS) and the reduced Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). The paired t-test was applied to compare changes in outcomes at three- and six-month follow-up. Effect size was calculated using Cohen's d standardized mean difference. Results In all patients, there was a reduction (p < 0.001) in VNRS at three months (2.87 ± 2.33) and at six months (3.07 ± 2.3) compared with the pretreatment pain score. There was also a reduction (p < 0.001) in WOMAC score at three months (4.8 ± 5.08) and at six months (4.42 ± 5.21). No adverse effects were reported in patients during the study period. Conclusions Intra-articular PRP injections may be safe and effective for pain relief and functional improvement for up to six months in all stages of knee OA. To the best of our knowledge, this is the first such study in a large sample of Arab patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.